A Case Report on Prolonged Response with Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting. Journal of Cancer Research Updates, [S. l.], v. 12, p. 49–53, 2023. DOI: 10.30683/1929-2279.2023.12.9. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/739. Acesso em: 22 oct. 2025.